Latest Accounting News

Page 1 of 356
Resonance Health delivered a $1.5 million profit and positive operating cash flow in every quarter of FY26, while raising $6 million to accelerate three growth programmes. The challenge is replacing a MASH trial that generated 48% of last year’s revenue.
Ada Torres
Ada Torres
19 Nov 2026
Acorn Capital Investment Fund Limited (ASX:ACQ) outperformed its benchmark in FY26 and maintained fully franked dividends, but its portfolio has since fallen 15.3% over 12 months. Shareholders also approved a new management agreement with Acorn Capital Limited at the annual meeting.
Claire Turing
Claire Turing
19 Nov 2026
Temas Resources has secured an estimated C$52,876 Stage 1 contract to test its Regenerative Chloride Leach technology on samples from an unnamed Québec mineral company. The nearby project could offer a regional processing opportunity, while a new governance appointment reshapes the board.
Victor Sage
Victor Sage
19 Nov 2026
Eden Innovations received US$538,896 of EdenCrete orders in the first seven weeks of Q2 FY27, more than four times Eden US sales in the preceding quarter. The figure includes a previously announced Holcim Ecuador order, while four new dispensing installations expand the base supporting future replenishment demand.
Victor Sage
Victor Sage
19 Nov 2026
Waratah Minerals has secured A$50 million from institutional investors to fund more than 100,000 metres of drilling at its Spur Gold Project in New South Wales. The raise gives the company a clear exploration runway, but also adds about 76.9 million shares and leaves most of the placement subject to shareholder approval.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Solaris Australian Equity Income Plus has opened a 1-for-3 entitlement offer targeting $63.4 million after firm placement and shortfall demand exceeded the full $91.97 million capital raising. The issue price is close to adjusted pre-tax NTA, but the offer remains non-underwritten and final shareholder take-up is yet to be determined.
Claire Turing
Claire Turing
19 Nov 2026
Actinogen Medical’s pivotal XanaMIA trial produced a mixed result: Xanamem showed a small, non-significant benefit across the full 247-patient population, but a prespecified older-patient analysis found a statistically significant difference in disease stabilisation. The company will continue its open-label extension, suspend future Phase 3 spending and seek development partners.
Victor Sage
Victor Sage
19 Nov 2026
Australian Agricultural Company has posted a 63% jump in first-half Operating Profit to $64.8 million as premium beef pricing and sales volumes strengthened. Statutory net profit fell 26%, however, after a smaller herd valuation gain and higher production costs weighed on the result.
Ada Torres
Ada Torres
19 Nov 2026
St Barbara is moving from asset sales to project delivery, with a potential A$453 million Simberi exit, Touquoy’s first gold targeted for January and A$475 million already in the bank. The main uncertainty is whether regulatory delays will slow its larger 15-Mile development in Nova Scotia.
Maxwell Dee
Maxwell Dee
19 Nov 2026
Textron is selling its Industrial segment to Kingswood Capital Management for US$1.2 billion, reshaping the group around aviation, rotorcraft and defence. The deal could return about US$1.1 billion in net proceeds, but it also brings a sizeable non-cash impairment before closing.
Victor Sage
Victor Sage
18 Nov 2026
Target delivered a stronger third quarter, with comparable sales, traffic and digital revenue all accelerating while the retailer raised its full-year sales outlook. The headline earnings gain was also helped by US$301 million in tariff refunds, leaving investors to separate operational improvement from a one-off benefit.
Logan Eniac
Logan Eniac
18 Nov 2026
Tasmea has upgraded FY27 earnings guidance for the second time this year after reporting a record first quarter and stronger-than-expected performance from Maxim and JPS. Shareholders also backed resolutions supporting its recent acquisitions, while rejecting Stephen Mayne’s board nomination.
Victor Sage
Victor Sage
18 Nov 2026

Browse the archive

Full archive